[144] Surgery Partners, Inc. SEC Filing

Rhea-AI Filing Summary

Surgery Partners, Inc. (SGRY) Form 144 reports a proposed sale of 25,000 common shares to be executed on 09/23/2025 through UBS Financial Services (Weehawken, NJ). The filing states these shares were acquired on 09/23/2025 as equity compensation through an equity option exercise from Surgery Partners, Inc. The notice is submitted under Rule 144 and includes the seller's representation that they are not aware of any undisclosed material adverse information about the issuer. The filing also discloses numerous recent open-market sales by the same person, dated between 08/21/2025 and 09/22/2025, across multiple transactions.

Positive

• Regulatory compliance: Form 144 filed, identifying broker and proposed sale date, indicating adherence to Rule 144 disclosure procedures
• Clear acquisition detail: Filing specifies acquisition method as equity option exercise with matching acquisition and proposed sale date

Negative

• Frequent insider sales: Multiple open-market sales by the same person between 08/21/2025 and 09/22/2025, which may attract investor attention
• Immediate disposition: Shares were acquired and proposed for sale on the same date (09/23/2025), indicating no long-term hold period for these shares

Insights

Securities Analyst

TL;DR Insider proposes to sell 25,000 shares acquired via option exercise; multiple recent sales are disclosed.

The filing is a routine Rule 144 notice showing compliance with required disclosure for an insider sale. The shares were acquired and are proposed to be sold on the same date, indicating an immediate disposition of newly exercised equity. The document lists several prior open-market sales by the same individual over the prior month, which may be notable for investors tracking insider activity but does not, by itself, provide information on company performance or material nonpublic facts.

Corporate Governance Expert

TL;DR Filing documents compliant insider sales; disclosures meet Rule 144 procedural requirements.

The Form 144 contains the necessary seller representations and broker identification, demonstrating procedural adherence to securities rules. It documents acquisition via equity compensation and identifies the broker and proposed execution date. While frequent insider sales are documented, the filing contains no statements about undisclosed material adverse information and does not reveal governance actions or changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	25000	550386.35	128209410	09/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	09/23/2025	equity compensation	Surgery Partners, Inc.			25000	09/23/2025	equity option exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/21/2025	100000	2299011
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/26/2025	25000	572717
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/27/2025	11865	271756
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/02/2025	25000	562150
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/03/2025	25000	560251
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/04/2025	25000	562756
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/05/2025	25000	563682
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/08/2025	2014	45207
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/11/2025	100000	2200741
Wayne DeVeydt 9910 Cumberland Drive Fisher IN 46037	common	09/12/2025	28700	628929
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/16/2025	25000	541518
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/17/2025	85785	1873875
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/18/2025	150000	3294425
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/19/2025	10613	234547
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/22/2025	50000	1092666

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for SGRY report?

The Form 144 reports a proposed sale of 25,000 common shares of Surgery Partners, Inc. to be executed on 09/23/2025 through UBS Financial Services.

How were the 25,000 shares acquired according to the filing?

The filing states the shares were acquired on 09/23/2025 as equity compensation via an equity option exercise from Surgery Partners, Inc.

Does the Form 144 show prior sales by the same person?

Yes. The filing lists multiple prior open-market sales by the same individual dated between 08/21/2025 and 09/22/2025, with varying amounts per transaction.

Which broker is named for the proposed sale?

The broker named is UBS Financial Services Inc, located at 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ 07086, for the proposed sale.

Does the filing disclose any undisclosed material information about SGRY?

The seller represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.